A licensing deal with Jiangsu Hengrui Pharmaceuticals puts Merck in a competitive race to develop a medicine that targets a ...

Merck has signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion, ...

Merck KGaA officials say that, ultimately, the SMARTfacturing transformation benefits its customers, patients, and the planet ...

Duska noted that the PD-L1 inhibitor pembrolizumab has shown efficacy in the treatment of recurrent or metastatic cervical ...

ADHD likely has a genetic component. If a biological parent or sibling has ADHD, you’re more likely to have it, too, but this doesn’t mean you will. Your environment can be influential as well.

The drugmaker Merck announced it has opened a $1 billion vaccine manufacturing facility in north Durham, a 225,000-square-foot addition to the company’s existing campus off Old Oxford Road.

(Reuters) -Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, as the drugmaker seeks to boost its U.S. manufacturing in the face of President Donald Trump's ...

Use of nivolumab (Opdivo) before chemotherapy was not associated with improved pathologic complete response (pCR) rates among patients with early triple-negative breast cancer (TNBC), but a 12-week ...

March 11 (Reuters) - A federal judge ruled in favor of Merck (MRK.N), opens new tab in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent cervical and other cancers ...

Brain cells, or oligodendrocytes (green), in the hippocampus are marked with a genetic marker in the mouse brain in the study. These cells often deteriorate during aging. Gadek et al., Science ...

Merck KGaA reaffirmed its strong performance ... in February 2025 for treating neurofibromatosis type 1 (NF1), a rare genetic disorder. According to GlobalData’s Pharma Intelligence Center ...